Table 2.
POP stage at baseline and at 12 months
| Anterior prolift | Posterior prolift | Anterior + posterior prolift | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compartment | Stage | Baseline (n = 35) | Follow-up (n = 35) | Success | Stage | Baseline (n = 78) | Follow-up (n = 77) | Success | Stage | Baseline (n = 34) | Follow-up (n = 33) | Success |
| Anterior | 0 | 0 | 26 (74%) | 89% (78–99)a | 0 | 23 (30%) | 29 (38%) | 60% (49–71) a | 0 | 0 | 22 (67%) | 79% (65–93)a |
| I | 0 | 5 (14%) | I | 36 (46%) | 17 (22%) | I | 0 | 4 (12%) | ||||
| II | 10 (29%) | 4 (11%) | II | 15 (29%)c4 | 27 (35%)c4 | II | 3 (9%) | 7 (21%) | ||||
| III | 25 (71%) | 0 | III | 4 (5%)c4 | 4 (5%)c3,e1 | III | 25 (73%) | 0 | ||||
| IV | 0 | 0 | IV | 0 | 0 | IV | 6 (18%) | 0 | ||||
| Apical | 0 | 10 (28%) | 26 (75%) | 86% (74–98)a | 0 | 27 (36%) | 59 (78%) | 94% (89–99)a | 0 | 3 (9%) | 13 (40%) | 76% (61–91)a |
| I | 22 (63%) | 4 (11%) | I | 44 (59%) | 12 (16%) | I | 9 (26%) | 12 (36%) | ||||
| II | 2 (6%) | 4 (11%) | II | 2 (2.5%) | 3 (4%) | II | 2 (6%) | 6 (18%) | ||||
| III | 1 (3%) | 1 (3%) | III | 2 (2.5%) | 1 (1%) | III | 13 (38%) | 2 (6%)f2 | ||||
| IV | 0 | 0 | IV | 0 | 1 (1%) | IV | 7 (21%) | 0 | ||||
| Posterior | 0 | 12 (34%) | 9 (26%) | 54% (37–71)a | 0 | 1 (1%) | 59 (77%) | 90% (83–97)a | 0 | 6 (18%) | 21 (64%) | 91% (81–100)a |
| I | 14 (40%) | 10 (28%) | I | 0 | 10 (13%) | I | 4 (12%) | 9 (27%) | ||||
| II | 9 (26%)b5 | 15 (43%)d2 | II | 45 (58%) | 8 (10%) | II | 11 (32%) | 2 (6%) | ||||
| III | 0 | 1 (3%)d1 | III | 32 (41%) | 0 | III | 8 (23%) | 1 (3%) | ||||
| IV | 0 | 0 | IV | 0 | 0 | IV | 5 (15%) | 0 | ||||
a95% confidence interval
bConcomitant posterior colporrhaphy (number)
cConcomitant anterior colporrhaphy (number)
dPosterior Prolift™ before 12-months follow-up (number)
eAnterior Prolift™ before 12-months follow-up (number)
fLaparoscopic cervicosacropexy or vaginal hysterectomy with high Mc Call procedure (number)